Mepact
Drug timelines are a Plus or Pro feature.
2 regulatory and trial events tracked for Mepact, covering 2025-09-22 to 2025-12-18. Get the full timeline:
Most recent: EMA Authorised: Mepact (mifamurtide) — Esteve Pharmaceuticals, S.A.
2 regulatory and trial events tracked for Mepact, covering 2025-09-22 to 2025-12-18. Get the full timeline:
Most recent: EMA Authorised: Mepact (mifamurtide) — Esteve Pharmaceuticals, S.A.